Fundraising Fox

Nihal Sinha

Investor

Partner at F-Prime Capital

London

Writes $100K – $10M checks · typically $5M

Find your path to Nihal

549 people in our graph share verified history with Nihal — schools, employers, funds. One of them is your warm intro.

Hannah SealunlockedNihal: together at University of Cambridge (2006–2008)
×9Nihal: together at University of Cambridge
Nihal: together at OXFORD UNIVERSITY HOSPITALS NHS TRUST
Nihal: together at NHS

Contact· self-published, not guessed

Experience

  1. F-Prime CapitalPartnercurrent2014 — presentLondon, United Kingdom
  2. ImmutrinBoard Directorcurrent2026 — presentCambridge
  3. T-Therapeutics LtdBoard Directorcurrent2023 — presentCambridge, England, United Kingdom
  4. CHARM TherapeuticsBoard Director, Founding Investorcurrent2021 — present
  5. EnsomaBoard Directorcurrent2023 — presentBoston, Massachusetts, United States
  6. AviadoBioBoard Directorcurrent2020 — presentLondon, England, United Kingdom
  7. Orchard TherapeuticsFounding Team2016 — 2019London, United Kingdom
  8. Fidelity BiosciencesAnalyst2013 — 2014
  9. The Boston Consulting GroupManagement Consultant2012 — 2013London, United Kingdom
  10. OXFORD UNIVERSITY HOSPITALS NHS TRUSTAcademic Clinical Fellow2010 — 2012Oxford, United Kingdom
  11. University of CambridgeNeuroscience Supervisor2005 — 2012
  12. NHSDoctor2008 — 2012
  13. University College London Hospitals NHS Foundation TrustAcademic Foundation Programme in Neurology2008 — 2010

Skills & more

Venture Capital50Healthcare62Life Sciences51Science21Neuroscience23Strategy18Clinical Research16Lifesciences13Management Consulting9Medicine12Entrepreneurship9Biotechnology14
+4 moreStart-upsBusiness DevelopmentLeadershipProject Management

From Nihal's professional profile.

Deals · 1

Antlia Bioscience, Inc.Board seat

via F-Prime Capital · filed Jun 2026 · $20M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at F-Prime Capital

Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Pasteur
Partner at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Amrit Jalan
Investor at Fine Structures Ventures
Andrew Bognanni
Director of Finance at F-Prime Capital Partners

Frequently asked questions

Who is Nihal Sinha?
Partner at F-Prime Capital Partners
Where does Nihal Sinha work?
Nihal Sinha is Partner at F-Prime Capital.
What check size does Nihal Sinha write?
Nihal Sinha typically writes checks of $100K – $10M.
What boards does Nihal Sinha sit on?
Nihal Sinha holds tracked board seats at Antlia Bioscience, Inc., CHARM Therapeutics.
What companies has Nihal Sinha invested in?
Investments tracked here include AvenCell, CHARM Therapeutics, Elucidata, Immutrin, Rigimmune, T Therapeutics.
Where did Nihal Sinha go to school?
Nihal Sinha studied at University of Cambridge (MB BChir, Medicine); Royal College of Physicians (MRCP, Medicine); University of Cambridge (MA, Physiology and Psychology).

Same school

Also attended University of Cambridge1,605

Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures

+ 1,599 more

Also attended Harrow School41

Leroy LimExecutive Advisor at TCVAde OkuwogaInvestor at HeadlineMaxwell JohnstonChief Business Officer at Apex GroupOliver WaltersChief Operating Officer at Commonwealth Asset ManagementRory WhitrowInvestment Manager at WestBridge LLPJason PontinGeneral Partner at DCVC (Data Collective)

+ 35 more

Also attended University of Oxford1,771

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 1,765 more

Shared employers

Also worked at Immutrin3

Michael AnsteyPartner at Cambridge Innovation CapitalMartin TaylorPrincipal at F-Prime Capital PartnersMahesh KudariSenior Associate at SR One Capital Management

Also worked at Orchard Therapeutics8

Bobby GasparVenture Partner at F-Prime Capital PartnersMahesh KudariSenior Associate at SR One Capital ManagementLaetitia SchwabPrincipal at SR One Capital ManagementBennett SmithSVP, Commercial at BerenFrank E. ThomasExecutive Officer at Orchard TherapeuticsNiamh AlixChief Human Resources Officer at Prime Medicine

+ 2 more

Also worked at Fidelity Biosciences243

Peter SaperstonePartner at GreycroftRob KniazInvestor at Hoxton VenturesHelen ClementInvestor at IVP (Institutional Venture Partners)Adiam BerhaneAccounting Manager at QED InvestorsAubrie PaganoGeneral Partner, Managing Member at Corigin VenturesJoanna Skoler GilmanChief Marketing and Communications Officer at .406 Ventures

+ 237 more

Also worked at The Boston Consulting Group1,469

Cristina JunqueiraCo-founder of NubankMassimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 VenturesLuca RossettoOperating Advisor at P101 Ventures

+ 1,463 more